|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
EBSCO_ocn947837521 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
160426s2016 nyua ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d YDXCP
|d OCLCF
|d EBLCP
|d SNK
|d DKU
|d AUW
|d IGB
|d D6H
|d VTS
|d AGLDB
|d G3B
|d S8J
|d S9I
|d STF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9781634842792
|q electronic bk.
|
| 020 |
|
|
|a 1634842790
|q electronic bk.
|
| 020 |
|
|
|z 9781634842785
|
| 029 |
1 |
|
|a AU@
|b 000062420142
|
| 035 |
|
|
|a (OCoLC)947837521
|
| 050 |
|
4 |
|a RC280.B7
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.99481
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Oligodendrogliomas (ODs) :
|b diagnosis, outcomes and prognosis /
|c Chad Reeves, editor.
|
| 246 |
3 |
0 |
|a Oligodendrogliomas
|
| 264 |
|
1 |
|a New York :
|b Nova Science Publishers, Inc.,
|c [2016]
|
| 300 |
|
|
|a 1 online resource :
|b illustrations.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Cancer etiology, diagnosis, and treatments
|
| 500 |
|
|
|a "Nova Biomedical."
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed May 9, 2016).
|
| 505 |
0 |
|
|a OLIGODENDROGLIOMAS (ODS) DIAGNOSIS, OUTCOMES AND PROGNOSIS ; OLIGODENDROGLIOMAS (ODS) DIAGNOSIS, OUTCOMES AND PROGNOSIS ; CONTENTS ; PREFACE ; Chapter 1 PATHOLOGY, MOLECULAR MECHANISMS AND CLINICAL REFERENCES OF OLIGODENDROGLIOMAS ; ABSTRACT; 1. INTRODUCTION; 1.1. The Origin of Oligodendroglioma; 1.2. Epidemiology; 1.3. Clinical Features; 1.4. Neuroradiological Features; 2. PATHOLOGY ; 2.1. Macroscopic Appearance ; 2.2. Microscopic Appearance ; OII ; OIII ; OAII ; OAIII; GBMO; 2.3. Microglia/Macrophages ; 2.4. Differential Diagnosis and Prognosis
|
| 505 |
8 |
|
|a 3. MOLECULAR GENETICS WITH REFERENCE TO DIFFERENTIAL DIAGNOSIS AND PROGNOSIS 3.1. 1p/19q Chromosomal Status ; 3.2. Mechanism of the Combined Loss of Chromosomes 1p and 19q ; 3.3. Methods for the Detection of 1p/19q Chromosomal Status ; 3.4. Candidate Tumor Suppressor Genes (TSGs) on 1p and 19q ; 3.5. IDH1/2 Mutations ; 3.6. Telomerase Reverse Transcriptase (TERT) Promoter Mutations ; 3.7. ATRX Mutations ; 3.8. CIC and FUBP1 Mutations ; 3.9. O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Hypermethylation and G-CIMP ; 3.10. Epithelial Membrane Protein 3 (EMP3)
|
| 505 |
8 |
|
|a 3.11. Anaplastic Oligodendroglioma 3.12. Pediatric Oligodendroglioma ; 3.13. GBMO ; 3.14. Timing and Relationships with Gliomagenesis ; 4. MICRORNAS (MIRNAS) ; 5. TREATMENT ; 6. PROGNOSIS ; CONCLUSION; ACKNOWLEDGMENT ; REFERENCES ; Chapter 2 MOLECULAR MARKERS OF OLIGODENDROGLIOMAS ; ABSTRACT ; INTRODUCTION ; EPIDEMIOLOGY AND AETIOLOGY ; TUMOUR SIGNS AND SYMPTOMS ; TREATMENT OF OLIGODENDROGLIAL TUMOURS ; HISTOPATHOLOGY AND NEUROONCOLOGY ; THE IMPORTANCE OF MOLECULAR MARKERS ; Chromosomes 1 and 19 and the Prognostic and Diagnostic Value of 1p and 19q Abnormalities ; MGMT Mutation
|
| 505 |
8 |
|
|a Hypermethylation Mutations in p53Gene ; Growth Factors and Other Genetic Abnormalities ; CONCLUSION; REFERENCES; Chapter 3 OLIGODENDROGLIOMA LOOK-ALIKES: THE HISTOPATHOLOGIC DIFFERENTIAL DIAGNOSIS ; ABSTRACT ; INTRODUCTION ; WHAT DOES OLIGODENDROGLIOMA LOOK LIKE? ; DIFFUSE ASTROCYTOMA VERSUS OLIGODENDROGLIOMA ; OLIGOASTROCYTOMA/MIXED GLIOMA VERSUS OLIGODENDROGLIOMA ; PILOCYTIC ASTROCYTOMA VERSUS OLIGODENDROGLIOMA ; PAPILLARY GLIONEURONAL TUMOR VERSUS OLIGODENDROGLIOMA; DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR VERSUS OLIGODENDROGLIOMA ; GANGLIOGLIOMA VERSUS OLIGODENDROGLIOMA
|
| 505 |
8 |
|
|a CENTRAL NEUROCYTOMA VERSUS OLIGODENDROGLIOMA CLEAR CELL EPENDYMOMA VERSUS OLIGODENDROGLIOMA ; ROSETTE-FORMING GLIONEURONAL TUMOR OF THE FOURTH VENTRICLE VERSUS OLIGODENDROGLIOMA ; INFLAMMATORY-RELATED LESIONS VERSUS OLIGODENDROGLIOMAS ; CONCLUSION; REFERENCES ; Chapter 4 LESSONS LEARNED FROM AWAKE BRAIN FUNCTION MAPPING IN AGGRESSIVE MULTIMODAL RESECTION OF OLIGODENDROGLIOMAS ; ABSTRACT ; INTRODUCTION; ROLE FOR SURGERY ; ONCOFUNCTIONAL BALANCE ; MAPPING; ANATOMO-FUNCTIONAL VARIABILITY ; PLASTICITY; SELECTED CASES ; ALTERNATIVES TO INTRA-OPERATIVE MAPPING ; SURGICAL ADJUVANTS
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Oligodendroglia.
|
| 650 |
|
0 |
|a Gliomas.
|
| 650 |
|
0 |
|a Nervous system
|x Tumors.
|
| 650 |
|
0 |
|a Brain
|x Tumors.
|
| 650 |
|
2 |
|a Oligodendroglia
|
| 650 |
|
2 |
|a Glioma
|
| 650 |
|
2 |
|a Nervous System Neoplasms
|
| 650 |
|
2 |
|a Brain Neoplasms
|
| 650 |
|
6 |
|a Oligodendroglie.
|
| 650 |
|
6 |
|a Gliome.
|
| 650 |
|
6 |
|a Système nerveux
|x Tumeurs.
|
| 650 |
|
6 |
|a Cerveau
|x Tumeurs.
|
| 650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Clinical Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Diseases
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL / Internal Medicine
|2 bisacsh
|
| 650 |
|
7 |
|a Brain
|x Tumors
|2 fast
|
| 650 |
|
7 |
|a Gliomas
|2 fast
|
| 650 |
|
7 |
|a Nervous system
|x Tumors
|2 fast
|
| 650 |
|
7 |
|a Oligodendroglia
|2 fast
|
| 700 |
1 |
|
|a Reeves, Chad,
|e editor.
|
| 830 |
|
0 |
|a Cancer etiology, diagnosis, and treatments.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1226077
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4586556
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1226077
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 12759158
|
| 994 |
|
|
|a 92
|b IZTAP
|
